Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP

Stem Cells

Volumn 30, Issue 2, 2012, Pages 197-209

  Buono, Roberta ^a,b   Vantaggiato, Chiara ^c   Pisa, Viviana ^a,b   Azzoni, Emanuele ^a,d   Bassi, Maria Teresa ^c   Brunelli, Silvia ^a,d   Sciorati, Clara ^a   Clementi, Emilio ^b,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SCIENTIFIC INSTITUTE   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Muscular dystrophy; Self renewal; Signal transduction; Skeletal muscle

Indexed keywords

ALPHA SARCOGLYCAN; CELL PROTEIN; CREATINE KINASE; CYCLIC GMP; MESSENGER RNA; MOLSIDOMINE; MYOGENIC FACTOR 5; MYOGENIN; NITRIC OXIDE; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG; VANGL2 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL FATE; CELL POLARITY; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; EX VIVO STUDY; EXTENSOR DIGITORUM LONGUS MUSCLE; IN VIVO STUDY; MOUSE; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE SATELLITE CELL; WILD TYPE;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC GMP; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, 129 STRAIN; MOLSIDOMINE; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; NERVE TISSUE PROTEINS; NITRIC OXIDE; NITRIC OXIDE DONORS; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE; SIGNAL TRANSDUCTION;

EID: 84856119982     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.783     Document Type: Article

References (85)

1. Paylor B, Natarajan A, Zhang RH et al. Nonmyogenic cells in skeletal muscle regeneration. Curr Top Dev Biol 2011;96:139-165.
2. Collins CA, Olsen I, Zammit PS et al. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 2005;122:289-301. (Pubitemid 41032991)
3. Buckingham M, Bajard L, Daubas P et al. Myogenic progenitor cells in the mouse embryo are marked by the expression of Pax3/7 genes that regulate their survival and myogenic potential. Anat Embryol 2006;211 (suppl 1):51-56.
4. Kuang S, Gillespie MA, Rudnicki MA.Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2008;2:22-31.
5. Fukada S, Uezumi A, Ikemoto M et al. Molecular signature of quiescent satellite cells in adult skeletal muscle. Stem Cells 2007;25:2448-2459. (Pubitemid 47582737)
6. Zammit PS.All muscle satellite cells are equal, but are some more equal than others?J Cell Sci 2008;121:2975-2982.
7. Relaix F, Marcelle C.Muscle stem cells. Curr Opin Cell Biol 2009;21:748-753.
8. Tedesco FS, Dellavalle A, Diaz-Manera J et al. Repairing skeletal muscle: Regenerative potential of skeletal muscle stem cells. J Clin Invest 2010;120:11-19.
9. Zammit PS, Partridge TA, Yablonka-Reuveni Z.The skeletal muscle satellite cell: The stem cell that came in from the cold. J Histochem Cytochem 2006;54:1177-1191. (Pubitemid 44623339)
10. Buckingham M.Skeletal muscle progenitor cells and the role of Pax genes. C R Biol 2007;330:530-533. (Pubitemid 47040689)
11. Scime A, Rudnicki MA.Anabolic potential and regulation of the skeletal muscle satellite cell populations. Curr Opin Clin Nutr Metab Care 2006;9:214-219. (Pubitemid 44097831)
12. Zammit PS, Relaix F, Nagata Y et al. Pax7 and myogenic progression in skeletal muscle satellite cells. J Cell Sci 2006;119:1824-1832. (Pubitemid 43811008)
13. Holterman CE, Rudnicki MA.Molecular regulation of satellite cell function. Semin Cell Dev Biol 2005;16:575-584. (Pubitemid 41247881)
14. Collins CA.Satellite cell self-renewal. Curr Opin Pharmacol 2006;6:301-306. (Pubitemid 43670904)
15. Emery AE.The muscular dystrophies. Lancet 2002;359:687-695. (Pubitemid 34203773)
16. McFarlane C, Hennebry A, Thomas M et al. Myostatin signals through Pax7 to regulate satellite cell self-renewal. Exp Cell Res 2008;314:317-329. (Pubitemid 350225602)
17. Yamada M, Tatsumi R, Yamanouchi K et al. High concentrations of HGF inhibit skeletal muscle satellite cell proliferation in vitro by inducing expression of myostatin: A possible mechanism for reestablishing satellite cell quiescence in vivo. Am J Physiol Cell Physiol 298:C465-C476.
18. Ge X, McFarlane C, Vajjala A et al. Smad3 signaling is required for satellite cell function and myogenic differentiation of myoblasts. Cell Res 2011;21:1591-1604.
19. Abou-Khalil R, Le Grand F, Pallafacchina G et al. Autocrine and paracrine angiopoietin 1/Tie-2 signaling promotes muscle satellite cell self-renewal. Cell Stem Cell 2009;5:298-309.
20. Shea KL, Xiang W, LaPorta VS et al. Sprouty1 regulates reversible quiescence of a self-renewing adult muscle stem cell pool during regeneration. Cell Stem Cell 2010;6:117-129.
21. Pisconti A, Cornelison DD, Olguin HC et al. Syndecan-3 and Notch cooperate in regulating adult myogenesis. J Cell Biol 2010;190:427-441.
22. Kuang S, Kuroda K, Le Grand F et al. Asymmetric self-renewal and commitment of satellite stem cells in muscleCell 2007;129:999-1010.
23. Waddell JN, Zhang P, Wen Y et al. Dlk1 is necessary for proper skeletal muscle development and regeneration. PLoS One 2010;5:e15055.
24. Perez-Ruiz A, Ono Y, Gnocchi VF et al. beta-Catenin promotes self-renewal of skeletal-muscle satellite cells. J Cell Sci 2008;121:1373-1382. (Pubitemid 351936302)
25. Le Grand F, Jones AE, Seale V et al. Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell 2009;4:535-547.
26. Brack AS, Conboy IM, Conboy MJ et al. A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2008;2:50-59.
27. Brack AS, Conboy MJ, Roy S et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007;317:807-810. (Pubitemid 47257918)
28. Ou CY, Kim JH, Yang CK et al. Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and beta-catenin and for anchorage-independent growth of human colon carcinoma cells. J Biol Chem 2009;284:20629-20637.
29. Otto A, Schmidt C, Luke G et al. Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration. J Cell Sci 2008;121:2939-2950.
30. Seale P, Polesskaya A, Rudnicki MA.Adult stem cell specification by Wnt signaling in muscle regeneration. Cell Cycle 2003;2:418-419.
31. Brack AS, Murphy-Seiler F, Hanifi J et al. BCL9 is an essential component of canonical Wnt signaling that mediates the differentiation of myogenic progenitors during muscle regeneration. Dev Biol 2009;335:93-105.
32. Filippin LI, Moreira AJ, Marroni NP et al. Nitric oxide and repair of skeletal muscle injury. Nitric Oxide 2009;21:157-163.
33. Stamler JS, Meissner G.Physiology of nitric oxide in skeletal muscle. Physiol Rev 2001;81:209-237. (Pubitemid 32096176)
34. Nisoli E, Clementi E, Carruba MO et al. Defective mitochondrial biogenesis: A hallmark of the high cardiovascular risk in the metabolic syndrome?Circ Res 2007;100:795-806. (Pubitemid 46555684)
35. Brenman JE, Chao DS, Xia H et al. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995;82:743-752.
36. Chao DS, Gorospe JR, Brenman JE et al. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med 1996;184:609-618. (Pubitemid 26324114)
37. Crosbie RH, Barresi R, Campbell KP.Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. FASEB J 2002;16:1786-1791. (Pubitemid 35340359)
38. Gucuyener K, Ergenekon E, Erbas D et al. The serum nitric oxide levels in patients with Duchenne muscular dystrophy. Brain Dev 2000;22:181-183. (Pubitemid 30256250)
39. Brunelli S, Sciorati C, D'Antona G et al. Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc Natl Acad Sci USA 2007;104:264-269. (Pubitemid 46068020)
40. Rosenblatt JD, Lunt AI, Parry DJ et al. Culturing satellite cells from living single muscle fiber explants. In Vitro Cell Dev Biol Anim 1995;31:773-779.
41. Ontell M.Muscle fiber necrosis in murine dystrophy. Muscle Nerve 1981;4:204-213. (Pubitemid 11098501)
42. Deponti D, Francois S, Baesso S et al. Necdin mediates skeletal muscle regeneration by promoting myoblast survival and differentiation. J Cell Biol 2007;179:305-319. (Pubitemid 350004894)
43. Brunelli S, Innocenzi A, Cossu G.Bhlhb5 is expressed in the CNS and sensory organs during mouse embryonic development. Gene Expr Patterns 2003;3:755-759. (Pubitemid 37451858)
44. Rando TA, Blau HM.Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 1994;125:1275-1287. (Pubitemid 24189532)
45. Sciorati C, Galvez BG, Brunelli S et al. Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J Cell Sci 2006;119:5114-5123. (Pubitemid 46085190)
46. Lincoln TM, Wu X, Sellak H et al. Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase. Front Biosci 2006;11:356-367. (Pubitemid 43253498)
47. Pilz RB, Broderick KE.Role of cyclic GMP in gene regulation. Front Biosci 2005;10:1239-1268.
48. Duclos F, Straub V, Moore SA et al. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol 1998;142:1461-1471. (Pubitemid 28452596)
49. Sciorati C, Miglietta D, Buono R et al. A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy. Pharmacol Res 2011;64:210-217.
50. Merrick D, Stadler LK, Larner D et al. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation. Dis Model Mech 2009;2:374-388.
51. Madhusoodanan KS, Murad F.NO-cGMP signaling and regenerative medicine involving stem cells. Neurochem Res 2007;32:681-694. (Pubitemid 46481298)
52. Doudney K, Ybot-Gonzalez P, Paternotte C et al. Analysis of the planar cell polarity gene Vangl2 and its co-expressed paralogue Vangl1 in neural tube defect patients. Am J Med Genet A 2005;136:90-92. (Pubitemid 40934238)
53. Torban E, Wang HJ, Groulx N et al. Independent mutations in mouse Vangl2 that cause neural tube defects in looptail mice impair interaction with members of the Dishevelled family. J Biol Chem 2004;279:52703-52713. (Pubitemid 39656646)
54. Phillips HM, Murdoch JN, Chaudhry B et al. Vangl2 acts via RhoA signaling to regulate polarized cell movements during development of the proximal outflow tract. Circ Res 2005;96:292-299. (Pubitemid 40279903)
55. Cossu G, Borello U.Wnt signaling and the activation of myogenesis in mammals. EMBO J 1999;18:6867-6872. (Pubitemid 30000439)
56. Brunelli S, Relaix F, Baesso S et al. Beta catenin-independent activation of MyoD in presomitic mesoderm requires PKC and depends on Pax3 transcriptional activity. Dev Biol 2007;304:604-614. (Pubitemid 46527564)
57. Peunova N, Scheinker V, Ravi K et al. Nitric oxide coordinates cell proliferation and cell movements during early development of Xenopus. Cell Cycle 2007;6:3132-3144.
58. Otto A, Collins-Hooper H, Patel A et al. Adult skeletal muscle stem cell migration is mediated by a blebbing/amoeboid mechanism. Rejuvenation Res 2011;14:249-260.
59. Wirth A.Rho kinase and hypertension. Biochim Biophys Acta 1802:1276-1284.
60. Hall JP, Merithew E, Davis RJ.c-Jun N-terminal kinase (JNK) repression during the inflammatory response? Just say NO. Proc Natl Acad Sci USA 2000;97:14022-14024. (Pubitemid 32016518)
61. Downey JM, Davis AM, Cohen MV.Signaling pathways in ischemic preconditioning. Heart Fail Rev 2007;12:181-188. (Pubitemid 350176691)
62. McConell GK, Wadley GD.Potential role of nitric oxide in contraction-stimulated glucose uptake and mitochondrial biogenesis in skeletal muscle. Clin Exp Pharmacol Physiol 2008;35:1488-1492.
63. Tews DS.Role of nitric oxide and nitric oxide synthases in experimental models of denervation and reinnervation. Microsc Res Tech 2001;55:181-186. (Pubitemid 33029631)
64. Manzur AY, Kuntzer T, Pike M et al. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 2004;CD003725.
65. Sampaolesi M, Blot S, D'Antona G et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006;444:574-579. (Pubitemid 44864430)
66. Sampaolesi M, Torrente Y, Innocenzi A et al. Cell therapy of alphasarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003;301:487-492. (Pubitemid 36900300)
67. Cirak S, Arechavala-Gomeza V, Guglieri M et al.Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: An open-label, phase 2, dose-escalation study. Lancet.
68. Goemans NM, Tulinius M, van den Akker JT et al. Systemic administration of PRO051 in Duchenne's muscular dystrophy. N Engl J Med 364:1513-1522.
69. Pichavant C, Aartsma-Rus A, Clemens PR et al. Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther 19:830-840.
70. Wehling M, Spencer MJ, Tidball JG.A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 2001;155:123-131. (Pubitemid 34286213)
71. Wehling-Henricks M, Oltmann M, Rinaldi C et al. Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy. Hum Mol Genet 2009;18:3439-3451.
72. Sciorati C, Buono R, Azzoni E et al. Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans. Br J Pharmacol 160:1550-1560.
73. Archer JD, Vargas CC, Anderson JE.Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort. FASEB J 2006;20:738-740. (Pubitemid 46671199)
74. Anderson JE.A role for nitric oxide in muscle repair: Nitric oxide-mediated activation of muscle satellite cells.Mol Biol Cell 2000;11:1859-1874. (Pubitemid 30307918)
75. Drenning JA, Lira VA, Simmons CG et al. Nitric oxide facilitates NFAT-dependent transcription in mouse myotubes. Am J Physiol Cell Physiol 2008;294:C1088-C1095. (Pubitemid 351507909)
76. De Palma C, Falcone S, Pisoni S et al. Nitric oxide inhibition of Drp1-mediated mitochondrial fission is critical for myogenic differentiation. Cell Death Differ 2010;14:1684-1696.
77. Tatsumi R, Liu X, Pulido A et al. Satellite cell activation in stretched skeletal muscle and the role of nitric oxide and hepatocyte growth factor. Am J Physiol Cell Physiol 2006;290:C1487-C1494. (Pubitemid 43830788)
78. Betters JL, Long JH, Howe KS et al. Nitric oxide reverses prednisolone-induced inactivation of muscle satellite cells. Muscle Nerve 2008;37:203-209. (Pubitemid 351214167)
79. Pisconti A, Brunelli S, Di Padova M et al. Follistatin induction by nitric oxide through cyclic GMP: A tightly regulated signaling pathway that controls myoblast fusion. J Cell Biol 2006;172:233-244. (Pubitemid 43112970)
80. Colussi C, Mozzetta C, Gurtner A et al. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci USA 2008;105:19183-19187.
81. Verma M, Asakura Y, Hirai H et al. Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice. Hum Mol Genet 19:4145-4159.
82. Voisin V, Sebrie C, Matecki S et al. L-Arginine improves dystrophic phenotype in mdx mice. Neurobiol Dis 2005;20:123-130. (Pubitemid 41219209)
83. Feelisch M, Ostrowski J, Noack E.On the mechanism of NO release from sydnonimines. J Cardiovasc Pharmacol 1989;14 (suppl 11):S13-S22. (Pubitemid 20313485)
84. Bailey SJ, Fulford J, Vanhatalo A et al. Dietary nitrate supplementation enhances muscle contractile efficiency during knee-extensor exercise in humans. J Appl Physiol 109:135-148.
85. Larsen FJ, Schiffer TA, Borniquel S et al. Dietary inorganic nitrate improves mitochondrial efficiency in humans. Cell Metab 13:149-159.